Companies: 10,795·Total market cap: $144.5T
Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd.

CANFAMEXHealthcare● Active
$3.08
$-0.01(-0.32%)
Market Cap$1657040
P/E Ratio—
52W High$23.4
52W Low$2.83
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Can-Fite BioPharma Ltd. (CANF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001536196 · CANF · AMEX · as of Jun 8, 2026

Filing snapshot

835
Total Filings
6-K
Latest Form
2026-06-04
Most Recent
2012
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001536196 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-26
Fiscal Year End
Mar 26, 2026
Accession No.
0001213900-26-034447
Primary Document
ea0282586-20f_canfite.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001536196 · Accession 0001213900-26-034447

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-04
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-04
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-02
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-28
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-18
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-13
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-30
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-23
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-23
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2026-04-06
View
EFFECTEFFECT
EFFECT
2026-04-03
View
424B3424B3
PROSPECTUS
2026-04-03
View
CORRESPCORRESP
CORRESP
2026-04-01
View
EFFECTEFFECT
EFFECT
2026-03-31
View
EFFECTEFFECT
EFFECT
2026-03-31
View
UPLOADUPLOAD
UPLOAD
2026-03-31
View
Showing 1–15 of 835 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001536196  |  Exchange: AMEX · Healthcare

Can-Fite BioPharma Ltd. (AMEX: CANF) has submitted 835 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2012. As a Healthcare sector company with CIK 0001536196, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Can-Fite BioPharma Ltd.'s most comprehensive regulatory disclosure. The most recent Can-Fite BioPharma Ltd. 10-K was filed on 2026-03-26 for fiscal year ending 2026. Historical CANF 10-K annual reports are available from 2011 through 2026.

Investors researching Can-Fite BioPharma Ltd. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
KZIA SEC Filings →SILO SEC Filings →SNGX SEC Filings →CMND SEC Filings →CNSP SEC Filings →OGEN SEC Filings →CLDI SEC Filings →GRI SEC Filings →
→ CANF Financials→ CANF Earnings→ CANF Insider Trades

Frequently Asked Questions

CANF SEC Filings · 8 questions

Can-Fite BioPharma Ltd. (CANF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 835 filings and access original documents at no cost. Can-Fite BioPharma Ltd.'s CIK is 0001536196.

CANF SEC filingsCan-Fite BioPharma Ltd. SEC documentsfind CANF 10-K